Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sternberg Z et al. – Luteolin reduced, in a dose–dependent manner, the proliferation of PBMC, and modulated the levels of IL–1beta and TNF–alpha released by PBMC in the culture supernatants. Luteolin reduced the MMP–9/TIMP–1 ratio via lowering MMP–9 production. In the majority of cases, luteolin, when combined with IFN–beta, had additive effects in modulating cell proliferation, IL–1beta, TNF–alpha, MMP–9 and TIMP–1.

Related Articles

APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis
Multiple Sclerosis, 11/19/09    Relevance Score: 69%

Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09    Relevance Score: 69%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09    Relevance Score: 69%

A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09    Relevance Score: 69%

Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address